Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)

Market Cap	19.09B
Revenue (ttm)	2.37B
Net Income (ttm)	1.92B
Shares Out	1.17B
EPS (ttm)	1.62
PE Ratio	10.07
Forward PE	n/a
Dividend	0.60 (3.73%)
Ex-Dividend Date	Nov 8, 2024

Volume	8,885,181
Average Volume	9,546,359
Open	16.25
Previous Close	16.28
Day's Range	16.20 - 16.42
52-Week Range	12.49 - 19.98
Beta	0.60
RSI	56.27
Earnings Date	Apr 19, 2025

About SHE:000623

Jilin Aodong Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China. The company provides various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, tonic medicines, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It is also involved in the highway construction and toll collection businesses; animal husbandry activities; manufacture of specialty chemicals; production and supply of heat...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1957
• Employees: 5,745
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000623

Financial Performance

In 2024, SHE:000623's revenue was 2.61 billion, a decrease of -24.31% compared to the previous year's 3.45 billion. Earnings were 1.55 billion, an increase of 6.27%.